$NIMU
NON INVASIVE MONITORING SYSTEMS INC /FL/

2023 Q4 Form 10-Q Financial Statement

#000149315223044788 Filed on December 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $75.00K $65.00K
YoY Change 15.38% 14.04%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $75.00K $65.00K
YoY Change 15.38% 14.04%
Operating Profit -$75.00K -$65.00K
YoY Change 15.38% 14.04%
Interest Expense $13.00K $6.000K
YoY Change 116.67% -700.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$88.00K -$71.00K
YoY Change 23.94% 22.41%
Income Tax
% Of Pretax Income
Net Earnings -$88.00K -$71.00K
YoY Change 23.94% 22.41%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 -$458.60
COMMON SHARES
Basic Shares Outstanding 154.8M shares 154.8M shares
Diluted Shares Outstanding 154.8M shares 154.8M shares

Balance Sheet

Concept 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $146.0K $89.00K
YoY Change 64.04% 2.3%
Cash & Equivalents $146.0K $89.00K
Short-Term Investments
Other Short-Term Assets $37.00K $39.00K
YoY Change -5.13% -18.75%
Inventory
Prepaid Expenses $37.00K $39.00K
Receivables
Other Receivables
Total Short-Term Assets $183.0K $128.0K
YoY Change 42.97% -5.19%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $183.0K $128.0K
Total Long-Term Assets $0.00 $0.00
Total Assets $183.0K $128.0K
YoY Change 42.97% -5.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $275.0K $241.0K
YoY Change 14.11% 4.33%
Accrued Expenses $20.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $300.0K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $326.0K $612.0K
YoY Change -46.73% 117.02%
LONG-TERM LIABILITIES
Long-Term Debt $500.0K $0.00
YoY Change -100.0%
Other Long-Term Liabilities $57.00K $0.00
YoY Change -100.0%
Total Long-Term Liabilities $557.0K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $326.0K $612.0K
Total Long-Term Liabilities $557.0K $0.00
Total Liabilities $883.0K $612.0K
YoY Change 44.28% 41.34%
SHAREHOLDERS EQUITY
Retained Earnings -$28.82M -$28.60M
YoY Change 0.78%
Common Stock $1.548M $1.548M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$700.0K -$484.0K
YoY Change
Total Liabilities & Shareholders Equity $183.0K $128.0K
YoY Change 42.97% -5.19%

Cashflow Statement

Concept 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$88.00K -$71.00K
YoY Change 23.94% 22.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$61.00K -$76.00K
YoY Change -19.74% -35.59%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $200.0K $150.0K
YoY Change 33.33% 0.0%
NET CHANGE
Cash From Operating Activities -$61.00K -$76.00K
Cash From Investing Activities
Cash From Financing Activities $200.0K $150.0K
Net Change In Cash $139.0K $74.00K
YoY Change 87.84% 131.25%
FREE CASH FLOW
Cash From Operating Activities -$61.00K -$76.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000720762
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
000-13176
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2007840
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
4400 Biscayne Blvd.
CY2023Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 180
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
CY2023Q4 dei City Area Code
CityAreaCode
(305)
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
575-4200
CY2023Q4 dei Security12b Title
Security12bTitle
Common Stock $0.01 par value per share
CY2023Q4 dei Trading Symbol
TradingSymbol
NIMU
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
true
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
154810655 shares
CY2023Q4 us-gaap Cash
Cash
146000 usd
CY2023Q3 us-gaap Cash
Cash
7000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
37000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
16000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
183000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
23000 usd
CY2023Q4 us-gaap Assets
Assets
183000 usd
CY2023Q3 us-gaap Assets
Assets
23000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
275000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
240000 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
51000 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
51000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
326000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
291000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
57000 usd
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
44000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
883000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
635000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154810655 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154810655 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154810655 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154810655 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1548000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1548000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26574000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26574000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28822000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28734000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-700000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-612000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
183000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
75000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
65000 usd
CY2023Q4 us-gaap Costs And Expenses
CostsAndExpenses
75000 usd
CY2022Q4 us-gaap Costs And Expenses
CostsAndExpenses
65000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-75000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-65000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
13000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
6000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-88000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-71000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154811000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154811000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154811000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154811000 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-612000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-88000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-700000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-413000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-413000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-71000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-484000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-484000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-88000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-71000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
21000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
33000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
35000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
22000 usd
CY2023Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
13000 usd
CY2022Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
6000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76000 usd
CY2023Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 usd
CY2022Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
150000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
200000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
139000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
74000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
146000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89000 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
51000 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
51000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-88000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-700000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146000 usd
CY2023Q4 NIMU Working Capital Deficit
WorkingCapitalDeficit
-143000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zL9I6tCHiYx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_znmZUUfNjIU5">Use of Estimates</span>. </i></b>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions, such as deferred taxes as estimates, that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of expenses during the reporting period. Actual results could differ materially from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
401000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2022Q4 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-23-044788-index-headers.html Edgar Link pending
0001493152-23-044788-index.html Edgar Link pending
0001493152-23-044788.txt Edgar Link pending
0001493152-23-044788-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nimu-20231031.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nimu-20231031_lab.xml Edgar Link unprocessable
nimu-20231031_pre.xml Edgar Link unprocessable
nimu-20231031_cal.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
nimu-20231031_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable